SEC 13F Intelligence

Rhenman & Partners Asset Management AB / LLY

Rhenman & Partners Asset Management AB’s Eli Lilly & Co Position

Does Rhenman & Partners Asset Management AB own Eli Lilly & Co (LLY)? Yes — 33.7K shares worth $31M (+3.83% of its 13F portfolio) as of Q1 2026, down from 42.2K shares the prior filed quarter.

Position Value
$31M
Q1 2026
Shares
33.7K
% of Portfolio
+3.83%
Quarters Held
29
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $14MQ4 ’18Q1 ’19: $13MQ2 ’19: $18MQ3 ’19: $17MQ4 ’19: $15MQ4 ’19Q1 ’20: $14MQ2 ’20: $17MQ3 ’20: $24MQ4 ’20: $30MQ4 ’20Q1 ’21: $32MQ2 ’21: $27MQ3 ’21: $34MQ4 ’21: $47MQ4 ’21Q1 ’22: $35MQ2 ’22: $29MQ3 ’22: $35MQ4 ’22: $32MQ4 ’22Q2 ’23: $38MQ3 ’23: $54MQ4 ’23: $45MQ1 ’24: $42MQ1 ’24Q2 ’24: $43MQ3 ’24: $42MQ4 ’24: $35MQ1 ’25: $34MQ1 ’25Q2 ’25: $45MQ3 ’25: $41MQ4 ’25: $45MQ1 ’26: $31MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202633.7K$31M+3.83%
Q4 202542.2K$45M+4.24%
Q3 202553.4K$41M+4.51%
Q2 202557.9K$45M+5.70%
Q1 202541.8K$34M+3.96%
Q4 202445.5K$35M+3.61%
Q3 202447.5K$42M+3.42%
Q2 202447.0K$43M+4.09%
Q1 202454.2K$42M+3.99%
Q4 202378.0K$45M+4.54%
Q3 2023100.0K$54M+5.79%
Q2 202381.0K$38M+4.00%
Q4 202288.0K$32M+3.36%
Q3 202297.0K$35M+3.68%
Q2 202290.0K$29M+3.32%
Q1 2022123.5K$35M+3.49%
Q4 2021170.0K$47M+3.13%
Q3 2021145.0K$34M+2.35%
Q2 2021118.8K$27M+1.85%
Q1 2021170.0K$32M+2.21%
Q4 2020180.0K$30M+2.48%
Q3 2020165.0K$24M+2.17%
Q2 2020105.0K$17M+1.86%
Q1 2020100.0K$14M+1.94%
Q4 2019111.4K$15M+1.61%
Q3 2019150.0K$17M+2.10%
Q2 2019160.0K$18M+1.95%
Q1 201998.7K$13M+1.50%
Q4 2018123.7K$14M+1.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of LLY.